COF trades above peers, but strong card growth, big acquisitions and rising revenues may justify the premium. Should investors wait?

Our team of savvy editors independently handpicks all recommendations. If you make a purchase through our links, we may earn a commission. Deals and coupons were accurate at the time of publication ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

US president Donald Trump hasn't given up on his approach to use tariffs as a way of gaining the upper hand in the global markets despite the monumental decision by the US Supreme Court on Feb. 20 ...

This award recognizes the most-read and -shared articles posted on JD Supra, a legal news service. WASHINGTON, DC, ...